Dexcom INC
-$1.9B
Net Activity
Institutions Holding
963
Popularity Rank
#471
Avg Weight
0.13%
Total Value
$23.2B
963 institutions currently hold DXCM, with 505 net buyers and 430 net sellers this quarter.
Institutional Moves (Q1 2026)
Neutral
Based on recent trading activity
Net Selling Institutions
430
Net Buying Institutions
505
Top 5 by Value
Across its top 20 institutional holders, DXCM's holder base skews toward low-concentration, low-turnover investors on average (avg. concentration score 5/100, avg. turnover score 23/100).
+$10.9B
Total Buy Value
$13.0B
Total Sell Value
505
Net Buyers
430
Net Sellers
Institutional and Insider Selling Align, DXCM Bearish
Signal Basis
Institutional net value change of -$1.9B in Q1 2026 shows heavy selling, despite higher buyer count; insiders sold $1.93M in July, confirming same direction.
Confirmation
Continued institutional net outflows and additional insider sales in the coming quarter would reinforce the bearish thesis.
Invalidation Risk
A reversal in institutional flows to net accumulation or cessation of insider selling would invalidate this view.
This game-theory analysis is AI-assisted and derived from public regulatory filings, covering historical data only. For informational purposes, not investment advice.
DXCM does not currently show a 13F-and-insider convergence signal — its insider confidence score is 0/100, below the threshold this product uses to flag combined buying pressure.
13F data as of 2026-06-30 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.
0
unique buyers
—
buy value
12-Month Buy/Sell Activity
| Action | Insider | Date | Value |
|---|---|---|---|
| Sell | Michael Jon Brown | 2026-07-15 | $127K |
| Sell | Kevin R Sayer | 2026-07-06 | $1.93M |
| Sell | Michael Jon Brown | 2026-03-16 | $110K |
| Sell | Heller Bridgette P | 2026-02-12 | $69K |
| Sell | Collins Richard Alexander | 2025-11-14 | $172K |
| Sell | Heller Bridgette P | 2025-11-12 | $59K |
| Buy | Leach Jacob Steven | 2025-11-10 | $139K |
| Buy | Leach Jacob Steven | 2025-11-10 | $863K |
5
Filings (90d)
$2.85M
Total Est. Value
39K shares
Planned Shares
| Filer | Filing Date | Est. Value |
|---|---|---|
| MICHAEL BROWN | 2026-07-15 | $127K |
| KEVIN R SAYER | 2026-07-06 | $1.93M |
| Brown Michael Jon | 2026-06-15 | $128K |
| FOLETTA MARK G | 2026-06-15 | $303K |
| Coleman Jon | 2026-06-04 | $364K |
Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。
No Schedule 13D/13G filings for this ticker
No Form 8-K filings for this ticker
252131107, 252131957
Other stocks in the same GICS sector
Institutions Holding
4,603
Total reported value
$438.8B
861 institutions currently hold both DXCM and this stock
Institutions Holding
4,337
Total reported value
$730.5B
886 institutions currently hold both DXCM and this stock
Institutions Holding
4,024
Total reported value
$283.9B
847 institutions currently hold both DXCM and this stock
The most-added stocks by 13F institutions this quarter
Institutions Holding
6,150
Total reported value
$2.1T
3245 13F institutions increased their position this quarter
Institutions Holding
5,957
Total reported value
$1.5T
3028 13F institutions increased their position this quarter
Institutions Holding
5,764
Total reported value
$3.0T
2743 13F institutions increased their position this quarter